Germany's N26 co-founder Tayenthal to step down as co-CEO N26 co-founder Maximilian Tayenthal will step away from his operational duties as co-CEO of the German digital bank on Dec. 31, as the company ...
The use of specialty drugs in the U.S. has skyrocketed in recent years driven primarily by an increase in chronic condition diagnosis and the number of new medications on the market. Krishnanjan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback